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Exercise Therapy or Angioplasty? A Summation Analysis
P. F. S. Chong, J. Golledge, R. M. Greenhalgh and A. H. Davies
Department of Vascular Surgery, Imperial College School of Medicine, Charing Cross Hospital, London,
U.K.
Objectives: to compare the outcome of exercise therapy or angioplasty for the treatment of patients with intermittent
claudication.
Design: a summation analysis.
Methods: a search using MEDLINE and PUBMED between 1966 and April 1999 followed by a review of the manuscripts
yielded 54 studies involving angioplasty and 27 studies involving exercise therapy for intermittent claudication. Studies
were only included (12 angioplasty and nine exercise series) when results were available for patients with intermittent
claudication alone, and when outcome was assessed in terms of symptoms at a minimum of 6 months.
Results: the total number of claudicants undergoing exercise therapy was 294 patients, with a mean symptomatic success
rate of 38.4% and a mean improvement in maximum walking distance of 189.7% at 6 months. The total number of
claudicants undergoing angioplasty was 2071, with a mean overall symptomatic success rate of 76.6%. The mean overall
complication rate was 9% and mean major complication rate was 2.7% for the angioplasty studies.
Conclusion: although the result demonstrates an advantage of angioplasty over exercise therapy at 6 months, there is a
small risk of major complications. However, comparison of studies was impaired due to disparity in patient numbers,
limited follow-up time and lack of uniformity in outcome assessment. In order to achieve a valid comparison of these
therapies in a future randomised study, a validated disease-specific instrument for the assessment of symptomatic outcome
for claudicants is required.
Key Words: Intermittent claudication; Exercise therapy; Angioplasty.
Introduction benefit over exercise therapy in intermittent clau-
dication.6–9 However, the number of patients in these
Intermittent claudication is a common and disabling studies may have been too small to identify differences
in outcome. In this summation analysis, we have com-symptom affecting between 3 and 7% of the popu-
lation1–4 and up to one in five patients over the age of pared the outcome of angioplasty and exercise therapy
for patients with intermittent claudication.75.3 The treatment of intermittent claudication can be
broadly classified into non-interventional conservative
therapy or interventional therapy, which comprises
endovascular techniques such as percutaneous trans-
Methodsluminal angioplasty or surgery. Conservative therapy
consists of risk factor reduction measures and exercise
A computer search was performed via MEDLINE andrehabilitation.5 The two randomised controlled trials
PUBMED using the keywords ‘‘angioplasty’’, ‘‘exercisecomparing exercise therapy and angioplasty have sug-
therapy’’, ‘‘peripheral vascular disease’’, ‘‘peripheralgested that angioplasty does not have any additional
arterial disease’’ and ‘‘intermittent claudication’’ for
abstracts published in the English language between
1966 and April 1999. Following an extensive hand-
∗ Please address all correspondence to: A. H. Davies, Department search and review of the manuscripts, 54 studies in-
of Vascular Surgery, Imperial College of School of Medicine, Charing volving angioplasty6–59 and 27 studies involving ex-Cross Hospital, Fulham Palace Road, London W6 8RF, United
Kingdom. ercise therapy6–9,60–82 for the treatment of intermittent
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claudication were identified. For this summation ana- Exercise therapy
lysis, studies were only included when results were
The total number of claudicants undergoing exerciseavailable for patients with intermittent claudication
therapy was 294 patients (Table 1). The mean symp-alone. Mixed angioplasty series involving patients with
tomatic success rate was 38.4% and the mean im-critical ischaemia as well as patients with intermittent
provement in maximum walking distance wasclaudication were rejected if the outcome results were
+189.70% at 6 months in the exercise group. Onlynot reported separately for intermittent claudication.
two exercise studies that met our entry criteria in ourStudies were also not included if the proportion of
analysis had follow-up for longer than 6 months.patients with symptomatic success at a minimum of 6
Six exercise studies were supervised and three weremonths was not documented. We defined symptomatic
unsupervised. None of the exercise programmes util-success as the doubling of the maximum walking
ised treadmill-walking in their training protocols anddistance (MWD) on exercise treadmill testing (100%
six studies utilised a programme of dynamic leg ex-increase) or the symptomatic improvement up at least
ercises as a main component of therapy. The numbersone category according to the subjective clinical criteria
for most of these studies were small and only onesuggested by the joint council of the Society for Vas-
study had more than 50 claudicants.63 This study wascular Surgery (SVS) and the North American Chapter
done by Ekroth et al. 20 years ago and had a programmeof the International Society for Cardiovascular Surgery
combining dynamic leg exercises and walking with(ISCVS) reporting guidelines.83,84 Results are either dir-
supervision 30 min a session, three times a week forectly quoted from the manuscripts or deduced from
6 months. It reported 41% of patients doubling theirlife-table/Kaplan–Meier displays. The numbers stated
maximum walking distance at 6 months. Apart fromfor the angioplasty series are based on an intention-to-
Mannarino et al., who used a graded-load treadmill-treat basis and include patients who have technically
walking test, all the other exercise studies utilised aunsuccessful procedures. The overall complication rate
fixed-load treadmill-walking test for evaluation of thewhich consists of both minor complications and major
maximum walking distance. None of the exercise stud-complications was identified for the angioplasty stud-
ies reported results stratified according to the locationies. Complications were defined as major if there was
of the diseased anatomical segment.a situation requiring transfusion or surgery, if acute
critical ischaemia of the limb developed, or if a patient’s
death is linked to the angioplasty procedure. Minor
Angioplasty studiescomplications were all other adverse events reported
by the authors not falling into our definition of a major
The total number of claudicants undergoing an-complication as described above.
gioplasty was 2071 in this analysis (Table 2). The mean
symptomatic success rate at 6 months was 76.6% in
the angioplasty group. These figures are based on an
intention-to-treat basis. There were six angioplasty
studies with 50 or more patients and these produced
Results relatively ‘‘uniform’’ results (range of 65% to 85%) at
6 months for symptomatic success.30,31,33,42–43,46 The mean
Our inclusion criteria yielded nine exercise therapy 6-month symptomatic success rates calculated on the
studies6,8,60–63,70–72,74 (Table 1) and 12 angioplasty studies6, basis of anatomical area angioplastied were 84.3% for
8,11,22,30,31,33,38,41–43,46 (Table 2). Studies, which were looked iliac segment studies11,34,41 and 67.4% for femoro-
at, but failed to meet our criteria, were excluded from popliteal segment studies.30,33,38,42,46 The mean technical
our analysis. The reasons for exclusion were, firstly, failure rate for angioplasty was 5.8%. Overall com-
a failure to report the outcome of angioplasty for plication rate for angioplasty was 9.0%, whereas the
intermittent claudication separately from the pro- mean major complication rate was 2.7%. The overall
cedures done for critical ischaemia,13,16,20,23,24,27,28,34,39,52,53, complication rate includes both minor and major com-
55–57 secondly, an omission of symptomatic im- plications following angioplasty. The most common
provement (or doubling of the MWD on a treadmill major complication was a haematoma requiring blood
test for exercise studies) as an outcome measure,10,17,18, transfusion, which occurred in 1.6% out of a total
26,29,35,42,44,48,80 thirdly, a failure to state the proportion of 1254 patients undergoing angioplasty, and deaths
of patients with symptomatic improvement12,69,73,75,78,97 directly linked to the procedure which occurred in 0.2%
and, lastly, studies that did not state the results of out of a total of 1254 patients undergoing angioplasty
(Table 3).follow-up at 6 months clearly.14,15,21,22,25,32,36,37,40,47,49–51,54,58,59
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Discussion there is a need for the development and validation of
a disease-specific quality-of-life tool for the assessment
The data from this comparison suggests that an- of claudicants and the comparison of therapeutic op-
tions.gioplasty provides better results at 6 months. However,
the analysis is more important in demonstrating the The Cochrane library review on exercise for in-
termittent claudication85 showed an overall im-difficulty in comparing exercise therapy versus an-
gioplasty for intermittent claudication. Comparison provement in walking ability of 150% in claudicants
whoexercised.Oursummation analysis showsa189.7%for a longer follow-up period was not possible, as all
except two of the exercise therapy studies did not improvement in maximum walking distance for those
in exercise studies. The results of Whyman,8,9 Alpert60report results beyond 6 months of follow-up. Although
this analysis suggests an advantage of angioplasty and Larsen70,71 suggest that unsupervised exercise ther-
apy with patient advice and encouragement mayover exercise therapy at 6 months, there are difficulties
in the comparison, which is hampered by the lack of achieve results similar to supervised programmes, but
it is difficult to come to any conclusions on the basis ofa uniform outcome assessment. The exercise studies
in our analysis reported outcome mainly in terms theseresultsbecause of thesmallnumbers ineachstudy.
Half of the supervised programmes consisted of ses-of treadmill walking distances utilising a fixed-load
treadmill for assessment. This has been shown in sions lasting 30 min, three times a week for at least 6
months.62,63,72 Gardner et al. reported, in a meta-analysisseveral studies to be inaccurate and poorly re-
producible in comparison to the graded-load treadmill of 21 trials to identify the components of exercise re-
habilitation programmes that were effective in im-test86–88 with coefficients of variation of 30–45% and
up to three tests required for a reproducible evalu- proving claudication symptoms, that the best regime
should use intermittent walking to near maximal paination.89 The poor reproducibility of the fixed-load
treadmill test led us to use the doubling of the MWD for at least 6 months.5 The optimal exercise programme
for claudicants still needs to be defined.to represent symptomatic success in this analysis as
opposed to initial walking distance (IWD). Chaudry Although angioplasty produced more favourable
results at 6 months, there is still a risk of complicationset al. have shown that the MWD is a more reproducible
value compared to the IWD using both fixed and both major and minor. The mean overall complication
rate in this summation analysis was 9%. This comparesgraded-load treadmill protocols.90 The doubling of the
MWD as a measure of symptomatic success is likely favourably with a reported 25% in a series of 175
patients undergoing angioplasty in a review by Sam-to be unrepresentative of the SVS/ISCVS criteria used
in the angioplasty series and highlights the need for son et al.53 The major complication rate was 2.7% in
our analysis and this was similar to 2.8% of patientsa uniform outcome assessment. Other problems in
result reporting are that angioplasty studies for in- undergoing surgery for complications following an-
gioplasty in a series of 1141 patients as reported bytermittent claudication often do not report results
separately for studies that include both patients with Belli et al.12 No complications were reported in the
exercise group, although there have been suggestionscritically ischaemic limbs and patients with in-
termittent claudication. There should also be agree- that exercise training in claudicants may trigger a
series of ischaemic reperfusion episodes leading toment on the definition of a successful outcome
following angioplasty. Anatomical or haemodynamic the generation of oxygen-derived free radicals,91 the
activation of neutrophils,92 and a generalised increasepatency rates alone are not adequate, as it is important
to know about symptomatic improvement as well. in vascular permeability.93,94 There are concerns that
this systemic endothelial inflammatory response mayThe main cause of disability in claudicants is the
impairment of walking ability due to pain. Therefore, not be beneficial and it has been postulated as a cause
for the two to three times increased mortality rateany treatment for intermittent claudication must im-
prove or prevent the deterioration in pain symptoms. observed in the claudicant population due to sec-
ondary cardiovascular events.95,96 However, Tisi97 hasThis means that as well as treadmill-walking distances
in exercise studies and anatomical/haemodynamic shown that the biological markers of the exercise-
induced inflammatory response can be attenuatedpatency in angioplasty patients, there must be an
attempt in future studies at the assessment of symp- through regular exercise training over 3–6 months and
thus the concern over adverse systemic effects may betomatic success in treated patients. What is required
is a measure of the impact of intermittent claudication unjustified.
In conclusion, this analysis suggests angioplastyon the patient’s daily routine activities. A few studies
have utilised generic quality-of-life questionnaires, but achieves better symptomatic outcome at 6 months than
Eur J Vasc Endovasc Surg Vol 20, July 2000
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